Nuvalent, Inc.
DelistedCIK 1861560fmd_0KMXZ7K64VXTSWE9JGEZDJ15E7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Mar 31, 2026, 25 periods
Latest annual · FY2025
Millions- Operating income
- (414)
- Net income
- (425)
Latest quarter · Q1 FY2026
Millions- Operating income
- (119)
- Net income
- (109)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Nuvalent, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$414.3 million | -$280.4 million | 10-K 2026-02-26 · proof | |
| Net income | -$425.4 million | -$260.8 million | 10-K 2026-02-26 · proof | |
| Cash from operating activities | -$275.2 million | -$185.1 million | 10-K 2026-02-26 · proof | |
| Total assets | $1.4 billion | $1.1 billion | +23.7% | 10-K 2026-02-26 · proof |
| Total liabilities | $164.4 million | $72 million | +128.4% | 10-K 2026-02-26 · proof |
| Cash and cash equivalents | $261.7 million | $145.7 million | +79.7% | 10-K 2026-02-26 · proof |
- What was Nuvalent, Inc.'s operating income in fiscal 2025?
- Nuvalent, Inc. reported operating income of -$414.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$280.4 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Nuvalent, Inc.'s net income in fiscal 2025?
- Nuvalent, Inc. reported net income of -$425.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$260.8 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Nuvalent, Inc.'s cash from operating activities in fiscal 2025?
- Nuvalent, Inc. reported cash from operating activities of -$275.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$185.1 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Nuvalent, Inc.'s total assets?
- As of Dec 31, 2025, Nuvalent, Inc. reported total assets of $1.4 billion, against $1.1 billion a year earlier (+23.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Nuvalent, Inc.'s total liabilities?
- As of Dec 31, 2025, Nuvalent, Inc. reported total liabilities of $164.4 million, against $72 million a year earlier (+128.4%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Nuvalent, Inc.'s cash and cash equivalents?
- As of Dec 31, 2025, Nuvalent, Inc. reported cash and cash equivalents of $261.7 million, against $145.7 million a year earlier (+79.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1861560&period_type=annual&limit=5"Information only, not investment advice.